Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-beta, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab
Author:
|
Kemmerer, C. L.; Pernpeintner, V.; Ruschil, C.; Abdelhak, A.; Scholl, M.; Ziemann, U.; Krumbholz, M.; Hemmer, B.; Kowarik, M. C.
|
Tübinger Autor(en):
|
|
Published in:
|
Plos One
(2020), Bd.
15,
Article e0235449
|
Verlagsangabe:
|
Public Library Science
|
Language:
|
English
|
Full text:
|
http://dx.doi.org/10.1371/journal.pone.0235449
|
ISSN:
|
1932-6203
|
DDC Classifikation:
|
500 - Natural sciences and mathematics 610 - Medicine and health
|
Dokumentart:
|
Article
|
Show full item record
|